Tue, November 7, 2017
Mon, November 6, 2017
Fri, November 3, 2017

Josh Schimmer Downgraded (BLUE) to Hold on, Nov 6th, 2017

-
Josh Schimmer of Evercore ISI Group, Downgraded "bluebird bio, Inc." (BLUE) to Hold on, Nov 6th, 2017.

Josh has made no other calls on BLUE in the last 4 months.



There are 6 other peers that have a rating on BLUE. Out of the 6 peers that are also analyzing BLUE, 3 agree with Josh's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, November 3rd, 2017
  • Biren Amin of "Jefferies" Downgraded from Strong Buy to Hold on, Wednesday, October 11th, 2017
  • Vincent Chen of "Bernstein" Initiated at Hold and Held Target at $109 on, Thursday, July 27th, 2017


These are the ratings of the 3 analyists that currently disagree with Josh


  • Dane Leone of "BTIG" Upgraded from Hold to Strong Buy on, Thursday, November 2nd, 2017
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $162 on, Thursday, November 2nd, 2017
  • Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $162 on, Monday, October 30th, 2017
-